Background: Evidence from epidemiological studies on the role of tea drinking in gastric cancer risk remains inconsistent. We aimed to investigate and quantify the relationship between tea consumption and gastric cancer in the Stomach cancer Pooling (StoP) Project consortium. Methods: A total of 9438 cases and 20,451 controls from 22 studies worldwide were included. Odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) of gastric cancer for regular versus non-regular tea drinkers were estimated by one and two-stage modelling analyses, including terms for sex, age and the main recognised risk factors for gastric cancer. Results: Compared to non-regular drinkers, the estimated adjusted pooled OR for regular tea drinkers was 0.91 (95% CI: 0.85–0.97). When the amount of tea consumed was considered, the OR for consumption of 1–2 cups/day was 1.01 (95% CI: 0.94–1.09) and for >3 cups/day was 0.91 (95% CI: 0.80–1.03). Stronger inverse associations emerged among regular drinkers in China and Japan (OR: 0.67, 95% CI: 0.49–0.91) where green tea is consumed, in subjects with H. pylori infection (OR: 0.68, 95% CI: 0.58–0.80), and for gastric cardia cancer (OR: 0.64, 95% CI: 0.49–0.84). Conclusion: Our results indicate a weak inverse association between tea consumption and gastric cancer.

Tea consumption and gastric cancer: a pooled analysis from the Stomach cancer Pooling (StoP) Project consortium / Martimianaki G.; Alicandro G.; Pelucchi C.; Bonzi R.; Rota M.; Hu J.; Johnson K.C.; Rabkin C.S.; Liao L.M.; Sinha R.; Zhang Z.-F.; Dalmartello M.; Lunet N.; Morais S.; Palli D.; Ferraroni M.; Yu G.-P.; Tsugane S.; Hidaka A.; Curado M.P.; Dias-Neto E.; Zaridze D.; Maximovitch D.; Vioque J.; Garcia de la Hera M.; Lopez-Carrillo L.; Hernandez-Ramirez R.U.; Hamada G.S.; Ward M.H.; Mu L.; Malekzadeh R.; Pourfarzi F.; Trichopoulou A.; Karakatsani A.; Kurtz R.C.; Lagiou A.; Lagiou P.; Boccia S.; Boffetta P.; Camargo M.C.; Negri E.; La Vecchia C.. - In: BRITISH JOURNAL OF CANCER. - ISSN 0007-0920. - ELETTRONICO. - 127:4(2022), pp. 726-734. [10.1038/s41416-022-01856-w]

Tea consumption and gastric cancer: a pooled analysis from the Stomach cancer Pooling (StoP) Project consortium

Boffetta P.;Negri E.;
2022

Abstract

Background: Evidence from epidemiological studies on the role of tea drinking in gastric cancer risk remains inconsistent. We aimed to investigate and quantify the relationship between tea consumption and gastric cancer in the Stomach cancer Pooling (StoP) Project consortium. Methods: A total of 9438 cases and 20,451 controls from 22 studies worldwide were included. Odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) of gastric cancer for regular versus non-regular tea drinkers were estimated by one and two-stage modelling analyses, including terms for sex, age and the main recognised risk factors for gastric cancer. Results: Compared to non-regular drinkers, the estimated adjusted pooled OR for regular tea drinkers was 0.91 (95% CI: 0.85–0.97). When the amount of tea consumed was considered, the OR for consumption of 1–2 cups/day was 1.01 (95% CI: 0.94–1.09) and for >3 cups/day was 0.91 (95% CI: 0.80–1.03). Stronger inverse associations emerged among regular drinkers in China and Japan (OR: 0.67, 95% CI: 0.49–0.91) where green tea is consumed, in subjects with H. pylori infection (OR: 0.68, 95% CI: 0.58–0.80), and for gastric cardia cancer (OR: 0.64, 95% CI: 0.49–0.84). Conclusion: Our results indicate a weak inverse association between tea consumption and gastric cancer.
2022
Tea consumption and gastric cancer: a pooled analysis from the Stomach cancer Pooling (StoP) Project consortium / Martimianaki G.; Alicandro G.; Pelucchi C.; Bonzi R.; Rota M.; Hu J.; Johnson K.C.; Rabkin C.S.; Liao L.M.; Sinha R.; Zhang Z.-F.; Dalmartello M.; Lunet N.; Morais S.; Palli D.; Ferraroni M.; Yu G.-P.; Tsugane S.; Hidaka A.; Curado M.P.; Dias-Neto E.; Zaridze D.; Maximovitch D.; Vioque J.; Garcia de la Hera M.; Lopez-Carrillo L.; Hernandez-Ramirez R.U.; Hamada G.S.; Ward M.H.; Mu L.; Malekzadeh R.; Pourfarzi F.; Trichopoulou A.; Karakatsani A.; Kurtz R.C.; Lagiou A.; Lagiou P.; Boccia S.; Boffetta P.; Camargo M.C.; Negri E.; La Vecchia C.. - In: BRITISH JOURNAL OF CANCER. - ISSN 0007-0920. - ELETTRONICO. - 127:4(2022), pp. 726-734. [10.1038/s41416-022-01856-w]
Martimianaki G.; Alicandro G.; Pelucchi C.; Bonzi R.; Rota M.; Hu J.; Johnson K.C.; Rabkin C.S.; Liao L.M.; Sinha R.; Zhang Z.-F.; Dalmartello M.; Lunet N.; Morais S.; Palli D.; Ferraroni M.; Yu G.-P.; Tsugane S.; Hidaka A.; Curado M.P.; Dias-Neto E.; Zaridze D.; Maximovitch D.; Vioque J.; Garcia de la Hera M.; Lopez-Carrillo L.; Hernandez-Ramirez R.U.; Hamada G.S.; Ward M.H.; Mu L.; Malekzadeh R.; Pourfarzi F.; Trichopoulou A.; Karakatsani A.; Kurtz R.C.; Lagiou A.; Lagiou P.; Boccia S.; Boffetta P.; Camargo M.C.; Negri E.; La Vecchia C.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/964011
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 8
  • ???jsp.display-item.citation.isi??? ND
social impact